Cargando…
Identification of CD112R as a novel checkpoint for human T cells
T cell immunoglobulin and ITIM domain (TIGIT) and CD226 emerge as a novel T cell cosignaling pathway in which CD226 and TIGIT serve as costimulatory and coinhibitory receptors, respectively, for the ligands CD155 and CD112. In this study, we describe CD112R, a member of poliovirus receptor–like prot...
Autores principales: | Zhu, Yuwen, Paniccia, Alessandro, Schulick, Alexander C., Chen, Wei, Koenig, Michelle R., Byers, Joshua T., Yao, Sheng, Bevers, Shaun, Edil, Barish H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749091/ https://www.ncbi.nlm.nih.gov/pubmed/26755705 http://dx.doi.org/10.1084/jem.20150785 |
Ejemplares similares
-
Neoadjuvant FOLFIRINOX Application in Borderline Resectable Pancreatic Adenocarcinoma: A Retrospective Cohort Study
por: Paniccia, Alessandro, et al.
Publicado: (2014) -
Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy
por: Torphy, Robert J., et al.
Publicado: (2017) -
The CD112R/CD112 axis: a breakthrough in cancer immunotherapy
por: Zeng, Taofei, et al.
Publicado: (2021) -
Anaplastic Pancreatic Carcinoma Arising Within a Mucinous Cystic Neoplasm of the Pancreas: A Case Report and a Brief Review of the Literature
por: Paniccia, Alessandro, et al.
Publicado: (2017) -
Examination of the TIGIT-CD226-CD112-CD155 Immune Checkpoint Network during a Healthy Pregnancy
por: Meggyes, Matyas, et al.
Publicado: (2022)